Back to search
FDAFDA · Food and drugs·Recall number D-0660-2020

Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ

Published January 22, 2020 · Recall initiated: December 26, 2019

Summary

FDA records drug Class II recall D-0660-2020, published January 22, 2020 and initiated December 26, 2019. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 207,585 blisters; Lot: JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sun Pharmaceutical Industries, Inc.
Distributor
Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
Lot
JKT4174A, exp. date 11/2021 JKU0622A, exp. date 01/2022 JKU1308A, exp. date 02/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ recalled?

Yes. FDA published recall D-0660-2020 on January 22, 2020. Reported hazard: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter